The international jury decided to grant 2 Prize Winners in 2023. It will fund a one-year-mobility for Jean Lemoine and Vincent Camus.

LYSA (The French Lymphoma Group, through its Endowment Fund, and ELI have decided to create a prize for young practitioners (clinicians and hospital biologists) in the course of their internship or post-internship, and wishing to pursue their activity in lymphoma research, in order to help them in their mobility.

Their projects were presented to the LYSA Days in Tours:

• MRD LYMPH Project – Vincent CAMUS

Implementation of a noninvasive genotyping tool for initial evaluation, response assessment, and monitoring of minimal residual disease in lymphomas

The MRD LYMPH project will be implemented in Pr. Davide Rossi at the Institute of Oncology Research from November 2023 to November 2024.

• OptiCART – Jean LEMOINE

Optimizing CAR T-cell efficacy by strengthening their interaction with tumor cells.

Jean Lemoine will join Marco Ruella’s lab at Pennsylvania University in the next few weeks for a year.